LYSOGENE Logo

LYSOGENE

LYS | PA

Overview

Corporate Details

ISIN(s):
FR0013233475
LEI:
969500T64RILK1RD0852
Country:
France
Address:
18 RUE JACQUES DULUD, 92200 NEUILLY-SUR-SEINE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Lysogene’s determination to succeed is rooted in our deep understanding of the impact central nervous system (CNS) diseases have on patients and families, and springs from our founder whose own child was affected by a neurodegenerative disease. Our mission is to discover and develop innovative therapies to transform the lives of people with rare central nervous system disorders. Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-26 17:32
Delisting Announcement
Informations privilégiées / Autres communiqués
French 84.9 KB
2023-05-26 17:32
Delisting Announcement
Inside Information / Other news releases
English 83.2 KB
2023-05-26 10:00
Delisting Announcement
Informations privilégiées / Autres communiqués
French 85.6 KB
2023-05-26 10:00
Legal Proceedings Report
Inside Information / Other news releases
English 83.5 KB
2023-05-15 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 83.5 KB
2023-05-15 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 85.6 KB
2023-04-29 18:00
Report Publication Announcement
Inside Information / News release on accounts, results
English 82.9 KB
2023-04-29 18:00
Delisting Announcement
Informations privilégiées / Communiqué sur comptes, résultats
French 85.1 KB
2023-04-14 18:00
M&A Activity
Inside Information / Other news releases
English 83.2 KB
2023-04-14 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 85.4 KB
2023-03-24 20:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 95.8 KB
2023-03-24 20:00
Regulatory News Service
Inside Information / Other news releases
English 93.5 KB
2023-02-16 18:00
Delisting Announcement
Inside Information / Other news releases
English 107.8 KB
2023-02-16 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 110.2 KB
2023-02-03 18:00
Board/Management Information
Informations privilégiées / Autres communiqués
French 91.3 KB

Automate Your Workflow. Get a real-time feed of all LYSOGENE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for LYSOGENE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany NMI
Alten Logo
Global engineering and IT consulting for digital transformation in industry and telecom sectors.
France ATE
Amoéba Logo
Develops amoeba-based natural fungicides for agriculture and active ingredients for cosmetics.
France ALMIB
APTAMER GROUP PLC Logo
Develops custom aptamer-based binders as antibody alternatives for life science applications.
United Kingdom APTA
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel ARAN
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP

Talk to a Data Expert

Have a question? We'll get back to you promptly.